Proteros tasked with delivering protein-ligand-structures of active fragments from Bayer HealthCare’s drug discovery programs.

Proteros biostructures achieved the first milestone of its research collaboration with Bayer HealthCare in the field of fragment-based protein crystallography.


Under the terms of the agreement, Proteros will also receive a copy of the jointly selected fragment library for its own use.


In the partnership, which started in June 2006, Proteros applies its target know-how, Free Mounting System, and Picodropper™ technologies to deliver protein-ligand-structures of active fragments from Bayer HealthCare’s drug discovery programs.

Previous articleGene Network Sciences Forms Alliance to Characterize Synergies between Two Cancer Drug Classes
Next articleNoven Receives $5.9M in ADHD Patch Partnership with Shire